Therapeutic apheresis in autoimmune and rheumatic diseases

Journal of Clinical Apheresis

Volumn 15, Issue 1-2, 2000, Pages 18-27

  Koo, Anna P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHERESIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; CRYOGLOBULINEMIA; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; RAYNAUD PHENOMENON; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; SYSTEMIC VASCULITIS;

EID: 0034024419     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1101(2000)15:1/2<18::AID-JCA3>3.0.CO;2-R     Document Type: Article

References (56)

1. Hunder G. Vasculitis. In: Kuppel, editor. Primer on the rheumatic diseases. Atlanta: Arthritis Foundation; 1997. p 299-303.
2. Berkman EM, Orlin JB. Use of plasmapheresis and partial plasma exchange in the management of patients with cryoglobulinemia. Transfusion 1980;20:171-178.
3. McLeod BC, Sassetti, RJ. Plasmapheresis with return of cryoglobulin depleted autologous plasma (cryoglobulin pheresis) in cryoglobulinemia. Blood 1980;55:866-870.
4. Bombardieri S, Maggiore Q, L'Abbate A, et al. Plasma exchange in essential mixed cryoglobulinemia. Plasma Ther Transfus Technol 1981;2:101-109.
5. Goronzy J, Weyland C. Rheumatoid arthritis. In: Klippel, editor. Primer on the rheumatic diseases. Atlanta: Arthritis Foundation; 1997. p 155-161.
6. Arnett FC, Edworthy SM, Block DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.
7. Paget S. Rheumatoid arthritis, treatment. In: Klippel, editor. Primer on the rheumatic diseases. Atlanta, Arthritis Foundation; 1997. p 168-174.
8. Jaffe I. Comparison of the effect of plasmapheresis and penicillamine on the level of circulating rheumatoid factor. Ann Rheum Dis 1963;22:71.
9. Rothwell R, Davis P, Gordon P, et al. A controlled study of plasma exchange in the treatment of severe rheumatoid arthritis. Arthritis Rheumatism 1980;23:785-790.
10. Karch J, Klippel J, Plotz P, et al. Lymphapheresis in rheumatoid arthritis: a randomized trial. Arthritis Rheumatism 1981;24:867-873.
11. Wallace D, Goldfinger, D, Lowe C, et al. A double-blind, controlled study of lymphoplasmapheresis versus sham apheresis in rheumatoid arthritis. N Engl J Med 1982;306:1406-1410.
12. Verdickdt W, Dequeker J, Ceuppens J, et al. Effect of lymphoplasmapheresis on clinical indices and T cell subsets in rheumatoid arthritis: a double-blind controlled study. Arthritis Rheumatism 1983;26:1419-1426.
13. Dwosh I, Giles A, Ford P. Plasmapheresis therapy in rheumatoid arthritis: a controlled, double-blind, crossover trial. N Engl J Med 1983;308:1124-1129.
14. Felson D, Durst D, LaValley M, et al. Results of a randomized double blind trial of the Prosorba column for treatment of severe rheumatoid arthritis. Arthritis Rheumatism 1998;41:S364.
15. Furst DE, Felson D, Gendreau M. Patients with severe rheumatoid arthritis responding to treatment respond again on retreatment. Arthritis Rheumatism 1998;41:S316.
16. Lichtin A. Idiopathic thrombocytopenic purpura: guidance amid uncertainty. Cleveland Clin J Med 1998;65:510-514.
17. Snyder HW Jr, Cochran SK, Balint JP, et al. Experience with protein A-immunoadsorbtion in treatment resistant immune thrombocytopenic purpura. Blood 1992;79:2237-2245.
18. Owen HG, Brecher ME. Atypical reactions associated with use of angiotensin converting enzyme inhibitors and apheresis. Transfusion 1994;34:891-894.
19. Cupps T. Vasculitis: epidemiology, pathology and pathogenesis. In: Klippel J, editor. Primer on the rheumatic diseases. Atlanta: Arthritis Foundation; 1997. p 289-293.
20. Hoffman G. Vasculitis: treatment. In: Klippel J, editor. Primer on the rheumatic diseases. Atlanta: Arthritis Foundation; 1997. p 301-304.
21. Lockwood CM, Rees AJ, Pinching AJ, et al. Plasma exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis. Lancet 1977;1:63-67.
22. Pusey CD, Rees AJ, Evans, DJ, et al. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 1991;40:757-763.
23. Guillevin L, Jarrousse B, Lok C, et al. Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange: a prospective randomized trial of 71 patients. J Rheumatol 1991;18:567-574.
24. Guillevin L, Fain O, Lhote F, et al. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome: a prospective, randomized trial in 78 patients. Arthritis Rheumatism 1992;35:208-215.
25. Pisesky D. Systemic lupus erythematosus. In: Klippel, editor. Primer on the rheumatic diseases. Atlanta: Arthritis Foundation; 1997. p 246-251.
26. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE). Arthritis Rheum 1982;25:1271-1277.
27. Klippel J. Systemic lupus erythematosus: treatment. In: Klippel J, editor. Primer on the rheumatic diseases. Atlanta: Arthritis Foundation; 1997. p 258-262.
28. Jones JV, Cumming RH, Bucknall RC, et al. Plasmapheresis in the management of acute systemic lupus erythematosus? Lancet 1976;1:709-711.
29. Parry HF, Moran CJ, Snaith ML, et al. Plasma exchange in systemic lupus erythematosus. Ann Rheum Dis 1981;40:224-228.
30. Jones JV. Plasmapheresis in SLE. Clin Rheum Dis 1982;8:243-260.
31. Habersetzer R, Samtleben W, Blumenstein M, Gurland HJ. Plasma exchange in systemic lupus erythematosus. Int J Artific Organs 1983;6:39-41.
32. Wei N, Klippel JH, Huston DP et al. A randomized trial of plasma exchange in mild systemic lupus erythematosus. Lancet 1983;1: 17-21.
33. Clark WF, Cattran DC, Balfe JW, et al. Chronic plasma exchange in systemic lupus erythematosus nephritis. Proc Eur Disl Transplant Assoc 1983;20:629-635.
34. Huston DP, White MJ, Maltiolo C, et al. A controlled trial of plasmapheresis and cyclophosphamide therapy of lupus nephritis. Arthrititis Rheumatism 1083;26:S33.
35. Lewis, EJ, Hunsiker LG, Lan SP, et al. A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 1992;326:1371-1379.
36. Euler HH, Schroeder JO, Zeuner RA, et al. A randomized trial of plasmapheresis and subsequent pulse cyclophosphamide in severe lupus: design of the LPSG trial. Int J Artif Organ 1991;14:639-646.
37. Schroeder JO, Schwab U, Zennet R, et al. Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus: preliminary results of the LPSG trial. Arthritis Rheumatism 1997;40:S325.
38. Pohl MA, Lan SP, Berl T. Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis: The Lupus Nephritis Collaborative Study Group. Ann Int Med 1991;114:924-929.
39. Schwartz RS, Silberstein LE, Berkman EM. Autoimmune hemolytic anemia. In: Hoffman R et al., editors. Hematology: basic principles and practice. New York: Churchill Livingston, Inc.; 1995. p 710-729.
40. Silberstein LE, Berkman EM. Plasma exchange in autoimmune hemolytic anemia (AIHA). J Clin Apheresis 1983;1:238-242.
41. Valbonesi M, Guzzin, D, Zerbi D, et al. Successful plasma exchange for a patient with chronic demyelinating polyneuropathy and cold agglutinin disease due to anti-Pr (a). J Clin Apheresis 1986;3:109-10.
42. Kutti J, Wadenvik H, Safai-Kutti S, et al. Successful treatment of refractory autoimmune hemolytic anemia by plasmapheresis. Scand J Hematol 1984;32:149-52.
43. Andersen O, Taaning E, Rosenkvist J, et al. Autoimmune hemlytic anemia treated with multiple transfusions, immunosuppressive therapy, plasma exchange and desferrioxamine. Acta Paediatr Scand 1984;73:145-8.
44. McConell ME, Atchison JAQ, Kohaut E, Castleberry RP: Successful use of plasma exchange in a child with refractory autoimmune hemolytic anemia. Am J Pediatr Hematol Oncol 1987;9: 158-60.
45. Hughes P, Toogood A. Plasma exchange as a necessary prerequisite for the induction of remission by human immunoglobulin in autoimmune haemolytic anemia. Acta Haematol 1994;91:166-9.
46. Silva VA, Seder RH, Weintraub LR. Synchronization of plasma exchange and cyclophosphamide in severe and refractory autoimmune hemolytic anemia. J Clin Apheresis 1994;9:120-3.
47. White B. Systemic sclerosis and related syndromes: epidemiology, pathology and pathogenesis. In: Klippel, editor. Primer on the rheumatic diseases. Atlanta: Arthritis Foundation; 1997. p 263-266.
48. Steen V. Systemic sclerosis and related syndromes: treatment. In: Klippel J, editor. Primer on the rheumatic diseases. Atlanta: Arthritis Foundation; 1997. p 273-275.
49. Weiner Sr, Kono DH, Osterman HA. Preliminary report on a controlled trial of apheresis in the treatment of scleroderma. Arthritis Rheum 1987;30:S24.
50. Rook AH, Freundlich B, Jegasothy BV, et al. Treatment of systemic sclerosis with extracorporeal photochemotherapy: results of a multicenter trial. Arch Dermatol 1992;128:1517-1520.
51. Wigley F. Clinical features of systemic sclerosis and related syndromes. In: Klippel J, editor. Primer on the rheumatic diseases. Atlanta: Arthritis Foundation; 1997. p 262-272.
52. Steen V. Systemic sclerosis and related syndromes: treatment. In: Klippel J, editor. Primer on the rheumatic diseases. Atlanta: Arthritis Foundation; 1997. p 273-275.
53. Talpos G, Horrocks M, White JM, et al. Plasmapheresis in Raynaud's disease. Lancet 1979;1:416-417.
54. O'Reilly MJG, Talpos G. Controlled trial of plasma exchange in treatment of Raynaud's syndrome. Br Med J 1979;1:1113-1115.
55. McCune MA, Winkelmann RK, Osmundson PJ, Pineda AA. Plasma exchange: a controlled study of the effects in patients with Raynaud's phenomenon and scleroderma. J Clin Apheresis 1983; 1:206-214.
56. Cotton LT. Plasmapheresis in Raynaud's disease. Lancet 1978;2: 108.